Analyst Price Target is $21.67
▲ +147.62% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Tscan Therapeutics in the last 3 months. The average price target is $21.67, with a high forecast of $22.00 and a low forecast of $21.00. The average price target represents a 147.62% upside from the last price of $8.75.
Current Consensus is
The current consensus among 4 investment analysts is to buy stock in Tscan Therapeutics.